---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-248669"
form_type: "8-K"
ticker: "OACC"
cik: "0002029769"
company_name: "Oaktree Acquisition Corp. III Life Sciences"
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:42:55.324200+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Oaktree Acquisition Corp. III Life Sciences completes $175M IPO, funds placed in trust for acquisition

## Summary
- Completed IPO of 17,500,000 units at $10.00 per unit, generating gross proceeds of $175,000,000.
- Private placement of 550,000 units to sponsor at $10.00 per unit, gross proceeds $5,500,000.
- Net proceeds $175,000,000 placed in trust account for benefit of public shareholders.
- On Oct 30, partial over-allotment exercise: 1,699,029 units ($16,990,290); sponsor bought 33,981 private placement units ($339,810).
- Audited balance sheet as of Oct 25, 2024 shows $177.1M total assets, $175M in trust, shareholders' deficit of $(5.5M).

## SEC filing metadata
- accession: 0001193125-24-248669
- form_type: 8-K
- ticker: OACC
- cik: 0002029769
- company_name: Oaktree Acquisition Corp. III Life Sciences
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2029769/000119312524248669/0001193125-24-248669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2029769/000119312524248669/d873991d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-248669
- JSON: https://secwatch.observer/filing/0001193125-24-248669.json
- Plain text: https://secwatch.observer/filing/0001193125-24-248669.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.